Salk Institute for Biological Studies

What Salk Institute for Biological Studies does

The Salk Institute for Biological Studies is an independent, nonprofit scientific research organization (501(c)(3)) founded in 1960 by Jonas Salk and headquartered in La Jolla, California. It conducts foundational basic research across cancer biology, neuroscience and neurological disorders, immunobiology, metabolism and diabetes, plant biology, computational biology, biochemistry and biophysics, and healthy aging, supported by 50+ faculty and a workforce of 501–1,000 employees. Core technology outputs include a 2,321-patent portfolio (U.S. and foreign through December 2025), proprietary platforms such as sonogenetics for noninvasive ultrasound-based cellular control, VIS-Fbs fluorescent nanobodies for live-cell molecular imaging, the YAF9B plant protein for CRISPR-related homology-directed repair, and the SLEAP AI-driven markerless motion capture software adopted globally by researchers.

Salk is one of only seven NCI-Designated Cancer Centers dedicated to basic laboratory research and the oldest in California, and its faculty includes 6 Nobel Laureates in physiology or medicine, 12 members of the National Academy of Sciences, and 8 highly cited scientists as of November 2025. The Institute's revenue model relies on a diversified mix of federal research grants (NIH, NCI, ARPA-H, CIRM), private foundation grants (Prebys, W. M. Keck, Helmsley, Audacious Project), individual and corporate philanthropy through tiered programs (Discovery Society, Corporate Discovery Partners, Partners in Research legacy giving), and technology transfer and licensing of its patent estate. Its primary customers and stakeholders are research collaborators across 40 countries, federal and state funding agencies, private foundations, individual donors, corporate partners, and graduate and postdoctoral trainees via its UCSD-affiliated academic training programs.

Distribution of research outputs occurs through peer-reviewed publications, scientific conferences, technology licensing agreements, collaborative research partnerships, and a multi-channel public engagement footprint spanning the Inside Salk magazine, monthly newsletter, Beyond Lab Walls and Salk Talk podcasts, Salk Streaming video platform, Symphony at Salk annual fundraiser, and the Science Can't Wait donor engagement campaign. The Institute is governed by a Board of Trustees and led by President Gerald Joyce, MD, PhD, and has earned Charity Navigator's 4-star rating for thirteen consecutive cycles.

Name

Salk Institute for Biological Studies

Legal name

Salk Institute for Biological Studies

Website

https://salk.edu

Company type

Private

Founded year

1960

Operating status

Operating

Headcount range

501–1,000 employees

Short description

The Salk Institute for Biological Studies is an independent nonprofit scientific research organization founded in 1960 in La Jolla, California, conducting foundational research in cancer, neuroscience, immunology, plant biology, computational biology, and aging. It serves the global scientific community, federal funders, private foundations, and trainees through its 50+ faculty, 2,321-patent portfolio, and multi-institution collaborations.

Ownership category

akta.pro rank

Product category

Biomedical Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industry

Life Sciences (Biology, Ecology, Agriculture) Scholarly Publishing (EDAGAFAC)

Keywords

• Biomedical research services
• Cancer biology research
• Neuroscience research
• Plant biology research
• Foundational biological research

Headquarters

HQ city

La Jolla

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Federal Research Grants: Primary funding from federal agencies including NIH, NCI-designated Cancer Center grant, CIRM for stem cell research, and ARPA-H for sonogenetics research. The Institute received up to $41.3M from ARPA-H for advancing sonogenetics as a noninvasive therapeutic.
2. Foundation Grants: Private foundation funding including W. M. Keck Foundation's $600,000 bridge funding initiative for early-career scientists and Prebys Foundation's $7 million emergency support package for San Diego's biomedical research sector.
3. Philanthropy and Donations: Individual donations, corporate partnerships through Corporate Discovery Partners program, legacy giving through Partners in Research, and membership in the Discovery Society premier donor program.
4. Technology Transfer and Licensing: Revenue from licensing research discoveries and intellectual property to pharmaceutical and biotechnology companies. The Institute holds 2,321 patents (U.S. and foreign) issued through December 2025.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels10 records

Core offering

The Salk Institute for Biological Studies is an independent nonprofit scientific research organization that conducts foundational, risk-taking biological research across cancer biology, neuroscience, immunology, aging, metabolism, computational biology, and plant biology. It delivers this research through peer-reviewed publications, technology licensing, and trained researchers, and supplements it with academic training programs, public communications (magazines, podcasts, video), and donor-supported membership and philanthropy programs.

Product overview

The Salk Institute for Biological Studies is an independent nonprofit scientific research organization, not a commercial product company. Its offerings consist of scientific research services, educational programs, membership/donation programs, publications, media content, and public events. The core offerings include: research publications and media (Inside Salk Magazine, monthly newsletter, Beyond Lab Walls and Salk Talk podcasts, Salk Streaming video platform); membership programs (Discovery Society with tiered circles, Corporate Discovery Partners program); planned giving (Partners in Research legacy program); public events (Symphony at Salk annual concert, Science Seminars); research funding initiatives (Science Can't Wait Innovation & Collaboration grants); and academic training (postdoctoral, graduate, and mentorship programs). These offerings support the Institute's mission to conduct foundational biological research addressing challenges in cancer, Alzheimer's, aging, immunology, and plant biology.

Differentiator

Problem solved

Functional benefit

Brands

• Symphony at Salk: Annual summer concert event featuring the San Diego Symphony Orchestra held at the institute's iconic oceanfront courtyard
• Inside Salk
• Beyond Lab Walls Podcast
• Discovery Society
• Science Can't Wait
• Corporate Discovery Partners

Products and services

• Academic Training Programs Postdoctoral and graduate training programs (including Salk faculty mentorship of UCSD PhD and MD/PhD students) for the next generation of biomedical researchers.
• Discovery Society Membership Program Tiered premier donor loyalty program (Chairman's Circle, Pioneer's Circle, Ambassador's Circle, Laureates Circle, Jonas Salk Circle) offering exclusive events and research access to visionary supporters.
• Corporate Discovery Partners Corporate philanthropy program with tiered support levels (Catalyst, Trailblazer, Vanguard, Visionary) enabling companies to align their brand with Salk's world-class science.
• Partners in Research (Legacy Giving) Planned giving program allowing supporters to include Salk in estate planning through cash, securities, retirement plans, real estate, and donor-advised funds.
• Science Can't Wait Innovation and Collaboration Grants Donor-funded peer-reviewed seed awards that provide early-stage research grants for high-risk, high-reward scientific experiments not typically supported by federal funding.
• Technology Licensing and Patent Portfolio Licensing of the Institute's portfolio of 2,321 issued US and foreign patents (through December 11, 2025) to pharmaceutical and biotechnology companies for commercialization, including breakthrough platforms such as sonogenetics and VIS-Fbs fluorescent nanobodies.

Quantifiable outcome

• One of only 7 NCI-Designated Cancer Centers dedicated to basic laboratory research
• +2 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Scripps ResearchcoreStrategic or Co-development PartnerCollaborating institution in the ARPA-H sonogenetics project alongside Salk Institute and other research institutions to translate sonogenetics into clinical applications.
• Duke UniversitycoreStrategic or Co-development PartnerCollaborating institution in the ARPA-H sonogenetics project to develop ultrasound-based therapeutic approaches.
• MITcoreStrategic or Co-development PartnerCollaborating institution in ARPA-H sonogenetics project and nanoparticle delivery development for cancer drug entinostat against pancreatic cancer.
• UC San DiegocoreStrategic or Co-development PartnerCollaborating institution in the ARPA-H sonogenetics project and partnership on genome-informed restoration of seagrass with Scripps Institution of Oceanography.
• California Medical Innovations InstitutecoreStrategic or Co-development PartnerCollaborating institution in the ARPA-H sonogenetics project for advancing sonogenetics into clinical applications.
• SonoNeuminorStrategic or Co-development PartnerStartup company collaborating in the ARPA-H-funded sonogenetics research program as part of the multi-institution effort to advance sonogenetics to clinic.
• Dana-Farber Cancer InstitutecoreStrategic or Co-development PartnerLed clinical trial testing vitamin D analog (paricalcitol) discovered in preclinical studies at Salk Institute, demonstrating it can be safely administered with chemotherapy for pancreatic cancer. Early evidence shows enhanced chemotherapy response and improved survival.
• Scripps Institution of Oceanography at UC San DiegominorStrategic or Co-development PartnerCollaboration on genome-informed restoration of seagrass in San Diego's Mission Bay, developing a hybrid seagrass to better withstand environmental threats for ecosystem restoration.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Howard Hughes Medical Institute (HHMI): The largest U.S. biomedical research nonprofit, funding and operating dozens of labs across HHMI Investigator sites. Directly comparable to Salk as an independent, research-only nonprofit that supports elite principal investigators in fundamental biological and biomedical discovery.
• Broad Institute of MIT and Harvard: Independent biomedical and genomic research institute affiliated with MIT and Harvard, operating as a 501(c)(3) focused on genomics, disease biology, and computational methods. Comparable to Salk in nonprofit research mission, federal grant dependence, and translation-oriented discovery.
• Scripps Research: Independent, nonprofit biomedical research institute also based in San Diego and a current Salk collaborator on the ARPA-H sonogenetics project. Closest geographic and structural peer, with overlapping focus areas in chemistry, neuroscience, immunology, and structural biology.
• Whitehead Institute for Biomedical Research: Independent nonprofit biomedical research institute affiliated with MIT, focused on foundational research in cancer, regenerative biology, and neurobiology. Highly comparable to Salk in size, mission, and integration with a major research university training pipeline.
• Cold Spring Harbor Laboratory: Independent nonprofit research institution focused on cancer biology, neuroscience, plant biology, and quantitative biology. Comparable to Salk as a foundational-research nonprofit with a strong training program and emphasis on high-risk, high-reward science.
• Allen Institute: Independent nonprofit research organization founded by Paul Allen, with major programs in brain science and cell science. Comparable to Salk in being a privately funded nonprofit driving large-scale, team-based basic research with public dissemination goals.
• Gladstone Institutes: Independent nonprofit biomedical research institute affiliated with UCSF, focused on cardiovascular, neurological, and immunological disease. Comparable to Salk in scale, nonprofit structure, federal grant reliance, and translation-focused discovery research.
• Stowers Institute for Medical Research: Independent nonprofit biomedical research organization in Kansas City focused on gene regulation, regeneration, and evolution. Comparable to Salk in being a privately endowed, research-only nonprofit dedicated to foundational biological discovery.
• Janelia Research Campus (HHMI): HHMI's dedicated basic research campus focused on neuroscience and imaging tool development. Comparable to Salk in funding model (HHMI) and emphasis on technology-driven discovery science rather than translational pipelines.
• The Jackson Laboratory: Independent nonprofit biomedical research institution focused on mammalian genetics and human disease models. Comparable to Salk as a research-only nonprofit supporting foundational discovery, training, and resource distribution to the scientific community.

Market position

Strengths5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/salkinstitute
• Facebookfacebook.com/salkinstitute
• LinkedInlinkedin.com/company/salk-institute-for-biological-studies

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds8 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Salk Institute for Biological Studies